Abstract
Targeted gene repair or targeted gene alteration is a molecular strategy that aims to correct single base mutations responsible for genetic diseases. The concept involves using single-stranded DNA oligonucleotides to direct a nucleotide exchange reaction at the genomic site of the mutation. Investigators have made significant progress in elucidating the mechanism(s) by which the mutation is corrected and have begun to focus on several viable targets that show great potential for clinical application. During the past several years, the field has witnessed a phase transition as the focus has switched from purely basic science to a sustained translational mode. We highlight the important advances over the last two to three years, some of which have moved the technology closer to the clinic while some others have introduced new reasons for caution.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Parekh-Olmedo H, Ferrara L, Brachman E, Kmiec EB . Gene therapy progress and prospects: targeted gene repair. Gene Therapy 2005; 12: 639–646.
Huen MS, Lu LY, Liu DP, Huang JD . Active transcription promotes single-stranded oligonucleotide mediated gene repair. Biochem Biophys Res Commun 2007; 353: 33–39.
Huen MS, Li XT, Lu LY, Watt RM, Liu DP, Huang JD . The involvement of replication in single-stranded oligonucleotide-mediated gene repair. Nucleic Acids Res 2006; 34: 6183–6194.
Wang Z, Zhou ZJ, Liu DP, Huang JD . Single-stranded oligonucleotide-mediated gene repair in mammalian cells has a mechanism distinct from homologous recombination repair. Nucleic Acids Res 2006; 3: 568–573.
Murphy BR, Moayedpardazi HS, Gewirtz AM, Diamond SL, Pierce EA . Delivery and mechanistic considerations for the production of knock-in mice by single-stranded oligonucleotide gene targeting. Gene Therapy 2007; 14: 304–315.
Radecke F, Peter I, Radecke S, Gellhaus K, Schwarz K, Cathomen T . Targeted chromosomal gene modification in human cells by single-stranded oligodeoxynucleotides in the presence of a DNA double-strand break. Mol Ther 2006; 6: 798–808.
Bertoni C . Oligonucleotide-mediated gene editing for neuromuscular disorders. Acta Myol 2005; 3: 194–201.
Igoucheva O, Alexeev V, Scharer O, Yoon K . Involvement of ERCC1/XPF and XPG in oligodeoxynucleotide-directed gene modification. Oligonucleotides 2006; 1: 94–104.
Dong C, Beetham P, Vincent K, Sharp P . Oligonucleotide-directed gene repair in wheat using a transient plasmid gene repair assay system. Plant Cell Rep 2006; 5: 457–465.
Suzuki T, Murai A, Muramatsu T . Bleomycin stimulates targeted gene repair directed by single-stranded oligodeoxynucleotides in BHK-21 cells. Int J Mol Med 2005; 4: 615–620.
Yin WX, Wu XS, Liu G, Li ZH, Watt RM, Huang JD et al. Targeted correction of a chromosomal point mutation by modified single-stranded oligonucleotides in a GFP recovery system. Biochem Biophys Res Commun 2005; 4: 1032–1041.
Olsen PA, Randol M, Luna L, Brown T, Krauss S . Genomic sequence correction by single-stranded DNA oligonucleotides: role of DNA synthesis and chemical modifications of the oligonucleotide ends. J Gene Med 2005; 7: 1534–1544.
Kolb AF, Coates CJ, Kaminski JM, Summers JB, Miller AD, Segal DJ . Site-directed genome modification: nucleic acid and protein modules for targeted integration and gene correction. Trends Biotechnol 2005; 8: 399–406.
Ciavatta VT, Padove SA, Boatright JH, Nickerson JM . Mouse retina has oligonucleotide-induced gene repair activity. Invest Ophthalmol Vis Sci 2005; 46: 2291–2299.
Olsen PA, Randol M, Krauss S . Implications of cell cycle progression on functional sequence correction by short single-stranded DNA oligonucleotides. Gene Therapy 2005; 12: 546–551.
Brachman EE, Kmiec EB . Gene repair in mammalian cells is stimulated by the elongation of S phase and transient stalling of replication forks. DNA Repair (Amst) 2005; 4: 445–457.
Engstrom JU, Kmiec EB . Manipulation of cell cycle progression can counteract the apparent loss of correction frequency following oligonucleotide-directed gene repair. BMC Mol Biol 2007; 8: 9.
Radecke S, Radecke F, Peter I, Schwarz K . Physical incorporation of a single-stranded oligodeoxynucleotide during targeted repair of a human chromosomal locus. J Gene Med 2006; 8: 217–228.
Sawitzke JA, Thomason LC, Costantino N, Bubunenko M, Datta S, Court DL . Recombineering: in vivo genetic engineering in E. coli, S. enterica, and beyond. Methods Enzymol 2007; 421: 171–199.
Igoucheva O, Alexeev V, Yoon K . Differential cellular responses to exogenous DNA in mammalian cells and its effect on oligonucleotide-directed gene modification. Gene Therapy 2006; 13: 266–275.
Ferrara L, Kmiec EB . Targeted gene repair activates Chk1 and Chk2 and stalls replication in corrected cells. DNA Repair (Amst) 2006; 5: 422–431.
Ferrara L, Engstrom JU, Schwartz T, Parekh-Olmedo H, Kmiec EB . Recovery of cell cycle delay following targeted gene repair by oligonucleotides. DNA Repair (Amst) 2007; 6: 1529–1535.
Aarts M, Dekker M, de Vries S, van der WA, Te RH . Generation of a mouse mutant by oligonucleotide-mediated gene modification in ES cells. Nucleic Acids Res 2006; 34: e147.
Dekker M, Brouwers C, Aarts M, van der TJ, de Vries S, van d V et al. Effective oligonucleotide-mediated gene disruption in ES cells lacking the mismatch repair protein MSH3. Gene Therapy 2006; 13: 686–694.
Maguire KK, Kmiec EB . Multiple roles for MSH2 in the repair of a deletion mutation directed by modified single-stranded oligonucleotides. Gene 2007; 386: 107–114.
Maude SL, Enders GH . Cdk inhibition in human cells compromises chk1 function and activates a DNA damage response. Cancer Res 2005; 65: 780–786.
Bertoni C, Morris GE, Rando TA . Strand bias in oligonucleotide-mediated dystrophin gene editing. Hum Mol Genet 2005; 14: 221–233.
Wu XS, Xin L, Yin WX, Shang XY, Lu L, Watt RM et al. Increased efficiency of oligonucleotide-mediated gene repair through slowing replication fork progression. Proc Natl Acad Sci USA 2005; 102: 2508–2513.
Andrieu-Soler C, Halhal M, Boatright JH, Padove SA, Nickerson JM, Stodulkova E et al. Single-stranded oligonucleotide-mediated in vivo gene repair in the rd1 retina. Mol Vis 2007; 13: 692–706.
Hu Y, Parekh-Olmedo H, Drury M, Skogen M, Kmiec EB . Reaction parameters of targeted gene repair in mammalian cells. Mol Biotechnol 2005; 29: 197–210.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Parekh-Olmedo, H., Kmiec, E. Progress and Prospects: targeted gene alteration (TGA). Gene Ther 14, 1675–1680 (2007). https://doi.org/10.1038/sj.gt.3303053
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.gt.3303053
Keywords
This article is cited by
-
Analyses of point mutation repair and allelic heterogeneity generated by CRISPR/Cas9 and single-stranded DNA oligonucleotides
Scientific Reports (2016)
-
Combinatorial gene editing in mammalian cells using ssODNs and TALENs
Scientific Reports (2014)
-
Transplantation of Gene-Corrected Motor Neurons as a Therapeutic Strategy for Spinal Muscular Atrophy
Molecular Therapy (2013)
-
Proliferation of Genetically Modified Human Cells on Electrospun Nanofiber Scaffolds
Molecular Therapy - Nucleic Acids (2012)
-
DNA Damage Response Pathway and Replication Fork Stress During Oligonucleotide Directed Gene Editing
Molecular Therapy - Nucleic Acids (2012)